Background: Urinary tract infections (UTIs) is a worldwide problem of all age groups and gender. Emerging resistance to antibiotics making difficult in the choice of treatment and management of UTI cases. This study sought to determine the gender wise prevalence of common uropathogens from UTI patients and the resistance profile of uropathogens against commonly used antibiotics.
Introduction
Urinary tract infections (UTI) fall into the category of either complicated or uncomplicated one and deem as one of the most common bacterial infections (Foxman, 2010) . In most cases uncomplicated UTIs affects those individuals who are salubrious and do not exhibit any structural or neurological urinary tract irregularities (Hooton, 2012; Nielubowicz & Mobley, 2010) . These infections are divided into upper UTIs (pyelonephritis) and lower UTIs (cystitis) (Hannan et al., 2012; Hooton, 2012) . Bacterial pathogens are perceived as the behind the cause of dispense symptoms, are treated with antibiotics ordinarily, in the case of primary care settings they account for nearly 95% of the antibiotic prescription for urinary tract infection (Ong, Kuyvenhoven, Van Dijk, & Verheij, 2008 ). An estimation is 2% of boys and 8% of the girls face with no less than one episode of UTI by the age of seven years and recurrences occur in 12-30 % of those cases within a year globally (Desai, Gilbert, & McBride, 2016) . Escherichia coli is conceded as the most frequent pathogen responsible for urinary tract infections among group II (13 to 40 years), group III (41 to 60 years) and group IV (>60 years). The selection of patients was according to the following criteria:
Inclusion Criteria
The patients with sign and symptoms of UTI including suprapubic pain, urgency, frequency and dysuria, were selected for this study.
Exclusion Criteria
The patients who received antimicrobials treatment within 48 hours prior to entry were excluded from the study.
Sample Size
The number of samples in this study was 4,480.
Laboratory Analysis
Mid-stream clean catch urine samples were collected in universal sterile containers (20 ml). The samples were streak on Cysteine Lactose Electrolyte Deficient (CLED) (Oxoid, UK) and blood agar (Oxoid, UK) media with a standardized wire loop and were incubated overnight at 37°C. Sterile calibrated wire loop of 0.001 liter (L) or 1 microliter (µL) were used for colony count of urinary isolates. Bacterial growth was reflected as per Kass count or Kass criteria i.e. (single species count more than 105 organism/ml of urine) (Kass, 2002) . Colonies were biochemically characterized according to the Borrows' guidelines (Barrow & Feltham) . Isolated colonies were further sub cultured on MacConkey (Oxoid, UK) and blood agar media (Oxoid, UK) to obtain the pure growth. Standardized identification (API 20 E, 20 NE and 20 Strip) system (Biomeriex, France) was used to identify and confirm the strain of isolates.
Antibiotic susceptibility testing of different uropathogens were determined by Kirby Bauer disk diffusion method (Boyle, Fancher, & Ross, 1973) . Muller Hinton Agar (MHA) agar media was used to evaluate the sensitivity and resistance pattern, pure bacterial colonies were spread on the MHA plates and were incubated for 24 hours at 35°C -37 °C. Zone of inhibition for bacterial growth were measured after incubation and compared as per CLSI guidelines (Orasch et al., 2014) . Both Gram negative and positive isolates were tested for sensitivity against different groups of antibiotics. A total of 846 uropathogens were subjected for antibiotic sensitivity pattern against 24 different types of antibiotics as shown in Table 1 . Descriptive statistics was used to analyze the data after entering the data into SPSS 21.0 and Microsoft Excel in order to see the distribution and pattern of antibiotic resistance among uropathogens.
Results
In this study total of 4,480 urine samples were analyzed. Among them, 3903 from Buraimi Hospital and 577samples from Primary Health Care. Significant bacteriuria were found in total 846 (19%) urine samples, out of those 745 (88%) samples obtained from Buraimi Hospital and 101 (12%) samples from Primary Health Centers, while remaining 3634 (81%) urine samples were observed either non-significant bacteria, very low bacteria or sterile. Out of 846 urine samples of significant bacteriuria 629 (74%) were female and 217 (26%) were male. Overall 728 (86%) Gram-negative and 118 (14%) Gram positive uropathogens were isolated from total (846) positive urine samples. Out of 728 uropathogens 542(74%) and 186(26%) uropathogens were isolated from female and male patients respectively ( Table 2 ). E.coli was found the highest prevalent (50.3%) uropathogens in UTI followed by Klebsiella species (13.9%), Pseudomonas (6.3%), A.baumannii (4%), E.Cloacae (2.2%), Proteus species (1.4%), Citrobacter species (1.2%), M. morgani (0.3%) and Serratia species (0.1%). The Extended Spectrum β Lactamase (ESBLs) producers pathogens were also isolated, the most prevalent were E. coli (16.6%) followed by Klebsiella species (2.5%) and Carbapenem Resistant Enterobacteriaceae (CRE) (Klebsiella) (0.1%). Total 118 (14%) Gram-positive uropathogens were isolated from urine samples among those 87 (74%) uropathogens from female and 31(26%) from male (Table 2) . Group "D" Streptococci were the most frequent occurring uropathogens (54.2%), followed by Group "B"Streptococci (31.4%), S.aureus (13.6%) and S. saprophyticus (0.8%). 
Total Gram Positive cocci 87 (74) 31 (26) 118 (14) Total 629 (74) 217 (26) 846 (100) Extended Spectrum Beta (β) Lactamases (ESBLs), Multipple Drug Resistant Organism (MDRO),Carbapenem-Resistant Enterobacteriaceae (CRE).
Overall, gender wise variation was found in percentage prevalence of uropathogens among different age groups of UTI patients. The highest prevalence of uropathogens was found in age group II in females with the highest percentage of Gram positive than Gram negative .In age group II from males, Gram negative isolates was found more than females. The least uropathogens was observed in the patients of age group I in both males and females. Gram negative urinary isolates were prevalent the most in both genders as shown in Figure 1 .
Patients of age ˂12 years were included in group I, 13-40 years in group II, 41-60 years in group III and ˃60 years are in group IV.
Figure 1. Age wise distribution of Gram (-/+) uropathogens among UTI patients
High variation was observed in antibiotic resistance pattern of uropathogens. The highest antibiotic resistance tendency (34.3%) was noticed in E.coli against Nalidixic Acid, however the least resistant against Ceftriaxone, Ceftazidime, Ciprofloxacin and Nitrufurantoin among female and male genders. On the other hand (24.8%) strains of E.coli were found positive for Extended Spectrum Beta Lactamase producers (ESBLs). E.coli (ESBLs) showed the highest (100%) resistance to Amoxicillin/Clavulanic Acid, Ceftazidime and Ceftriaxone, similarly this group of uropathogens were least resistant to Amikacin, Colistin Sulphate, Meropenem, Polymyxin B and Nitrofurantoin. Klebsiella species were found the second frequently occurring Gram negative uropathogens, it has shown the highest (13.8%) resistant to Nitrofurantoin and Nalidixic Acid, while the least resistant (1.3%) to Ceftriaxone, Ceftazidime and Ciprofloxacin among female (Table 3) and male (Table 4) . Besides this, (15%) strains of Klebsiella species were positive for Extended Spectrum Beta (β) Lactamase producers (ESBLs) .Similarly, Extended Spectrum Beta (β) Lactamase producers (ESBLs) Klebsiella pneumoniae showed the highest (100%) resistanace to Aoxicillin/Clavulanic Acid, Ceftazidime and Ceftriaxone like other Extended Spectrum Beta lactamase producers (ESBLs), however the least (0%) resistant trend were observed against Amikacin, Colistin Sulphate, Meropenem and Polymyxin B among female and male genders. Pseudomonas species showed the maximum (5.7%) resistant to Ceftazidime and Meropenem, while the least (0%) resistant to Amikacin and Piperacillin/Tazobactam among female gender, however no resistance were observed against Amikacin, Ceftazidime, Ciprofloxacin, Meropenem and Piperacillin/Tazobactam among male gender. Moreover, (9.8%) of Pseudomonas Species were Multi Drug Resistant Organism (MDRO) (Pseudomonas aeroginosa strains) that showed the highest resistant (100%) to Ceftazidime, Ciprofloxacin, Meropenem and Piperacillin/Tazobatam among female gender, however these strains showed the least (0%) resistance to Colistin Sulphate and Polymyxin B among both genders. Acinetobacter baumannii, exhibited the highest resistant to Ceftazidime and Ciprofloxacin among female and male genders, while this uropathogens were the least resistant (0%) to Meropenem, Trimethoprim/Sulphamethoxazole and Piperacillin/Tazobactam among both genders. Similarly, (9.4%) of A. baumannii strains were found Multi Drug Resistant Organisms (MDRO), these strains exhibited maximum (100%) resistant to Amikacin, Ceftazidime, Ciprofloxacin, Meropenem, and Piperacillin/Tazobactam among female and male genders, however these strains showed the least resistant (0%) to Colistin Sulphate and Polymyxin B in each gender. Enterobacter cloacae showed the highest (100%) resistant pattern against Amoxicillin/Clavulanic acid, Nitrofurantoin and Cefuroxime among both genders, however this strain showed the least (18%) resistant to Ceftazidime, Ciprofloxacin, and Nalidixic acid among female gender, however, (0%) resistant were observed against Ceftazidime, Ciprofloxacin,and Nalidixic Acid among male gender. Citrobacter species, showed the peak (100%) resistant pattern against Amoxicillin/Clavulanic acid among female gender, however these bacterium showed the highest (100%) resistant to Aoxicillin/Clavulanic acid, Ciprofloxacin and Nalidixic acid among male gender, on the other hand, the least resistant were observed against Ciprofloxacin, Cefotaxime and Nitrofurantoin among female gender, however, these bacterium showed the least (0%) resistant to Amikacin, Ceftazidime,Nitrofurantoin among male gender. Proteus species on the other hand, showed the highest resistant (100%) pattern against Nitrofurantoin among both genders, however the least (0%) resistant were observed against Ciprofloxacin, Ceftriaxone and Cefotaxime among female gender, however, the least (0%) resistant were observed against Amoxicillin/Clavalonic acid, Ceftazidime, Ceftriaxone, Ciprofloxacin and Nalidixic Acid among male gender. Serratia species, the least encounter uropathogens isolated from female gender, showed the highest (100%) resistant against Amoxicillin/Clavulanic acid, Cefuroxime, Nitrofurantoin and Nalidixic acid, however this uropathogens showed the least (0%) resistant pattern against Ceftazidime, Ciprofloxacin and Cefotaxime. Table 4 showed the disparity in sensitivity pattern of uropathogens among males. K. pneumoniae (0.8%) CRE (Carbapenem Resistant Enterobacteriacae) isolated from male gender only, showed the highest (100%) resistance against Amikacin, Augmentin, Ceftazidime, Gentamicin, Ceftriaxone, Ciprofloxacin, Nitrofurantoin, Meropenem, Nalidixic Acid, however this strain showed no Resistant to Colistin Sulphate and Polymyxin. Similarly, Morganella morganii were isolated from male gender only, showed the highest (100%) resistant pattern against Amoxicillin/Clavalonic acid, Cefuroxime and Nitrofurantoin, however this bacterium show the least (0%) resistant to Ceftazidime and Ciprofloxacin. Group "B" Streptococci were found high sensitive to Augmentin, Ampicillin, Ciprofloxacin, Ceftriaxone and Cefuroxime among both genders however, no resistant were observed against Augmentin, Ampicillin, Ciprofloxacin, Ceftriaxone and Cefuroxime. S. saprophytics showed the highest (100%) Resistant to Novobiocin and the least (0%) to Amoxicillin/Clavalonic acid, Ciprofloxacin, Nitrofurantoin, Ceftriaxone and Trimethoprim/Sulphamethaxazole. Group"D" Streptococci (Enterococcus faeculis) presented high resistance (14.6%) to Ciprofloxacin and Ampicillin (7.3%) among female gender and Ciprofloxacin (34.7%), Ampicillin (13%) and Nitrofurantoin (8.6%) among male gender, this bacterium showed the least (0%) Resistant to Amoxacillin/Clavalonic acid and Vancomycin among female and male genders respectively as shown in Table 6 . 
Discussion
The purpose of current study to focus the condition of antimicrobial resistant pattern in uropathogens to monitor and support to improve treatment of urinary tract infections (UTI). It is a retrospective study where routine diagnostic results and susceptibility analysis are exercise and used. The results may not reflect the true prevalence as most patients are treated empirically for Urinary Tract Infection (UTIs). This study indicated that UTI is more common in female (74%) than males (26%) that is similar with previous study in 2017, India with 73.97% in females and 26.02%) UTI prevalence to males (Lawhale & Naikwade, 2017) and other studies (Dash, Padhi, Mohanty, Panda, & Parida, 2013; Oladeinde, Omoregie, Olley, & Anunibe, 2011; Shah, Wasim, & Abdullah, 2015) . Possible reasons for common UTI in females including short urethra, close proximity of vagina with urethral meatus, rich microbial flora with rectal mucosa and sexual intercourse have been reported (Oladeinde et al., 2011; Shah et al., 2015) . Current study observed high UTI in females of age group 13-40 years. This age group reported high risk for UTI cases and contribute highly sexually active women group (Dash et al., 2013; Nalini, Meenakshi, & Ramya, 2013; Shaifali, Gupta, Mahmood, & Ahmed, 2012) . Nalini et al. (2013) and Dash et al. (2013) also presented the same results. Among males, the most common UTI influenced age group was 13-40 years unlike other study that reported 44.4% age group 61-80 years (Lawhale & Naikwade, 2017) .
Among total 4,480 urine samples, 846 (18.8%) sample were positive for significant bacteriuria. Gram-negative organisms however, were the most frequent uropathogens, which account for (86%) UTI cases. This study results were found similar to the research conducted in Sultan Qaboos Uiniversity hospital, Oman, reported in a literature (El-Naggari et al., n.d.) . Results from present study have shown E.coli the most common prevalent (66.9%) uropathogens, in comparison with other studies from Pakistan that indicated the E. coli prevalence (62%) to (68 %) in urinary samples (Keah, Wee, Chng, & Keah, 2007; Kothari & Sagar, 2008) . Klebsiella species was the second highest prevalent uropathogens accounting for (16.5%) of cases. Studies from United Kingdom (UK) reported 8-26% occurrence of Klebsiella species in UTI cases (Hasan et al., 2007) . Our study results revealed the highest (16.6%) presence of ESBL producing E. coli and followed by (16.5%) Klebsiella species, (15%) Klebsiella pneumonia ESBLs prducers, Pseudomonas species (7%), A. baumannii (4.4%), Enterobacter species (2.2%), Proteus species (1.4%), Citrobacter species (1.2%), M.morgani (0.3%) and Serratia species (0.1%) respectively.
Results from this study exhibited that (14%) UTI were contributed through Gram-positive cocci. Group "D" Streptococci was the most frequent (54.2%) uropathogens and the prevalence of these organisms were found higher in male than female (74.2%) and (47.1%) respectively. Whereas group "B" Streptococci were the second frequently (31.4%) occurring Gram positive uropathogens, though the occurrence of this organism was higher in female than male (35.6%) and (19.3%) respectively. A previous study indicated the prevalence of Gram positive uropathogens including E. faecalis (15%) followed by S. aureus (1%) (Sohail, Khurshid, Saleem, Javed, & Khan, 2015) .
The results indicated the variations in sensitivity pattern of gram negative uropathogens among males and female. Nalidixic acid and Ciprofloxacin showed the highest 34.3% and 10% resistant pattern to E. coli. In comparison with other study conducted in India that found E. coli more high resistance to antibiotics like doxycycline (65%), cephalosporins (60%) and levofloxacin (52.01%) (Lawhale & Naikwade, 2017 ). Nitrofurantoin and Cefotaxime followed by Ceftriaxone and Ceftazidime were found susceptible in females against males. Whereas in males sensitivity were observed against Ceftazidime, Ceftriaxone and Nitrofurantoin.
ESBLs producing E. coli have exhibited the peak resistant (100%) to Penicillin, Cephalosporin and Azetrenom (Augmentin, Ceftazidime and Ceftriaxone) for both genders. Similar findings were presented in other studies with 100%, 100% resistant to ampicillin and 92%, 80.8% resistant to non ESBL producing E.coli respectively (Elsayed, Ismail, & Elgamal, 2017; Islam et al., 2015) . However, ESBLs producing E. coli displayed the sensitivity to Amikacin, Polymyxin B, Colistin Sulphate and Meropenem. Klebsiella species presented the highest resistance to Nalidixic Acid and Nitrofurantoin among female and male genders. In previous studies from India, K. pneumoniae showed resistance to doxycycline (82.85%) cephalosporin (63.33%), levofloxacin 75.23% (Dash et al., 2013; Fajfr 
